Vermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th
AUSTIN, Texas, July 27, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its second quarter 2017 financial results on Tuesday, August 8, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.
| Tuesday, August 8th @ 4:30pm Eastern Time |
|
| Domestic: |
888-437-9274 |
| International: |
719-325-2437 |
| Conference ID: |
8515049 |
| Webcast: |
|
| Replays, Available through August 22nd |
|
| Domestic: |
844-512-2921 |
| International: |
412-317-6671 |
| Replay PIN: |
8515049 |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
[email protected]
SOURCE Vermillion, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article